Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD1775 and Paclitaxel in TP53-Mutated Gastric Cancer
NCT02448329Phase 2Completed
- Sponsor
- Samsung Medical Center
- Start
- Jan 2015
- Primary completion
- Dec 2019
- Countries
- 1
01
Overview
A Phase 2 trial of adavosertib in gastric adenocarcinoma, sponsored by Samsung Medical Center. Started Jan 2015; status: completed.
02
Drugs
adavosertib
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT02448329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02448329.